Next-generation biobanking of metastases to enable multidimensional molecular profiling in personalized medicine-Reference-Cited by-同舟云学术

Next-generation biobanking of metastases to enable multidimensional molecular profiling in personalized medicine

Published:2013-06-07 Issue:11 Volume:26 Page:1413-1424
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Diaz Zuanel,Aguilar-Mahecha Adriana,Paquet Eric R,Basik Mark,Orain Michèle,Camlioglu Errol,Constantin André,Benlimame Naciba,Bachvarov Dimcho,Jannot Guillaume,Simard Martin J,Chabot Benoit,Gologan Adrian,Klinck Roscoe,Gagnon-Kugler Thérèse,Lespérance Bernard,Samson Benoit,Kavan Petr,Alcindor Thierry,Dalfen Richard,Lan Cathy,Chabot Catherine,Buchanan Marguerite,Przybytkowski Ewa,Qureshi Samia,Rousseau Caroline,Spatz Alan,Têtu Bernard,Batist Gerald

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol201381.pdf

Reference43 articles.

1. Sequist LV, Waltman BA, Dias-Santagata D et al. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci Transl Med 2011;3:75ra26.

2. Nazarian R, Shi H, Wang Q et al. Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation. Nature 2010;468:973–977.

3. Vignot S, Besse B, André F et al. Discrepancies between primary tumor and metastasis: a literature review on clinically established biomarkers. Crit Rev Oncol Hematol 2012;84:301–313.

4. Kim E, Herbst R, Wistuba I et al. The BATTLE trial: personalizing therapy for lung cancer. Cancer Disc 2011;1:44–53.

5. Barker AD, Sigman CC, Kelloff GJ et al. I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy. Clin Pharmacol Ther 2009;86:97–100.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Regulatory Landscape of Biobanks In Europe: From Accreditation to Intellectual Property;Current Genomics;2024-07-30

2. A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line Therapy;International Journal of Molecular Sciences;2023-12-19

3. Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinoma;Frontiers in Immunology;2023-12-08

4. Robust Acquisition of Spatial Transcriptional Programs in Tissues With Immunofluorescence-Guided Laser Capture Microdissection;Frontiers in Cell and Developmental Biology;2022-03-25

5. Processing and Analysis of Tissue Samples from Esophageal Cancer Patients in an African Setting;Biopreservation and Biobanking;2021-08-12